glp 1 small molecule Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies A potent novel small molecule

Customers exchanged over 6.7 million messages with their care teams, with 75% receiving responses in 5 hours or less 3

Myalgic encephalomyelitis: A baffling syndrome with a tragic aftermath

Not only is obesity connected to heart disease, diabetes, certain types of cancer, and other serious health conditions, but a 2024 analysis estimates that obesity accounts for nearly $173 billion in annual healthcare system costs and over $347 billion in direct employer and employee costs, underscoring the massive economic burden tied to obesity in the U.S

The honest answer is that the human safety data is limited compared to decades-old pharmaceuticals, but the preclinical safety record across multiple species is unusually clean for a peptide with this level of biological activity